Brief: Kezar Reports Q4 And Year-End 2021 Financial Results

Kezar Life Sciences

17/03/2022 20:03

March 17 (Reuters) - Kezar Life Sciences Inc  KZR.O :
    * KEZAR REPORTS FOURTH QUARTER AND YEAR-END 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
    * Q4 LOSS PER SHARE $0.25
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED
$208.4
MILLION AS OF YEAR-END 2021

Source text for Eikon:  ID:nBw2W0lNLa 
Further company coverage:  KZR.O 

 ((Reuters.Briefs@thomsonreuters.com;))